SCHEMBL28522188

SCHEMBL28522188

O=POc1ccc(CC(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.52
▸ CAMK2A Q9UQM7 1/20 0.52
▸ SRD5A2 P31213 2/20 0.50
▸ AKR1B1 P15121 1/20 0.50
▸ FFAR1 O14842 1/20 0.48
▸ PTGS1 P23219 2/20 0.48
▸ GAA P10253 2/20 0.48
▸ ABCC4 O15439 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ POLB P06746 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ AKR1C3 P42330 1/20 0.47
▸ AKR1C2 P52895 1/20 0.47
▸ KLKB1 P03952 1/20 0.46
▸ CTSB P07858 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7755976 0.82 CTBP2 (0.38) CA2CAMK2ASRD5A2HTTPOLB
SCHEMBL7760941 0.81 FFAR1 (0.61) SRD5A2FFAR1LMNA
SCHEMBL28368266 0.79 FFAR1 (0.59) SRD5A2FFAR1LMNA
SCHEMBL21243832 0.79 SRD5A2 (0.72) CA2CAMK2ASRD5A2AKR1B1FFAR1
SCHEMBL2999416 0.79 SRD5A2 (0.72) CA2CAMK2ASRD5A2AKR1B1FFAR1
SCHEMBL69614 0.78 CA2 (0.79) CA2CAMK2AAKR1B1FFAR1PTGS1
SCHEMBL6549531 0.77 LTA4H (0.48) CA2TSHR
SCHEMBL23751423 0.75 SRD5A2 (0.58) CA2CAMK2ASRD5A2AKR1B1FFAR1
SCHEMBL7409326 0.75 CA2 (0.56) CA2CAMK2ASRD5A2AKR1B1FFAR1
SCHEMBL18861120 0.75 CA2 (0.56) CA2CAMK2ASRD5A2AKR1B1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112203661-A Compositions comprising a difluoroalkyl-1, 4-benzodiazepine compound and an immunotherapeutic agent and methods of using the same 艾雅拉制药公司 2021-01-08 — — CN claimed
CN-112203661-A Compositions comprising a difluoroalkyl-1, 4-benzodiazepine compound and an immunotherapeutic agent and methods of using the same 艾雅拉制药公司 2021-01-08 — — CN disclosed
Send feedback